4//SEC Filing
Guerin Mark Patrick 4
Accession 0001415889-23-011867
CIK 0001130598other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:45 PM ET
Size
8.6 KB
Accession
0001415889-23-011867
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-02+4,750→ 26,866 total - Tax Payment
Common Stock
2023-08-03$1.02/sh−1,422$1,450→ 25,444 total - Exercise/Conversion
Restricted Stock Units
2023-08-02−4,750→ 4,750 total→ Common Stock (4,750 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001607714
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:45 PM ET
- Size
- 8.6 KB